TGFB1 and lung carcinoma: CircR-0003222 directly up-regulates PD-L1 expression and sponges miR-527 to activate the Transforming growth factor-β/SMAD family (TGF-β/SMAD) signaling pathway, ultimately promoting lung cancer progression and anti-PD-L1 inhibitor resistance [137].